Global Human Chorionic Gonadotropin Market Growth (Status and Outlook) 2024-2030

December 2024 | 89 pages | ID: G924C1E1F210EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Human Chorionic Gonadotropin market size was valued at US$ 1893.9 million in 2023. With growing demand in downstream market, the Human Chorionic Gonadotropin is forecast to a readjusted size of US$ 3333.7 million by 2030 with a CAGR of 8.4% during review period.

The research report highlights the growth potential of the global Human Chorionic Gonadotropin market. Human Chorionic Gonadotropin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Chorionic Gonadotropin. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Chorionic Gonadotropin market.

Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta.

hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men.

Key Features:

The report on Human Chorionic Gonadotropin market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Human Chorionic Gonadotropin market. It may include historical data, market segmentation by Type (e.g., Natural Source Extraction, Recombinant Technology), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Chorionic Gonadotropin market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Chorionic Gonadotropin market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Human Chorionic Gonadotropin industry. This include advancements in Human Chorionic Gonadotropin technology, Human Chorionic Gonadotropin new entrants, Human Chorionic Gonadotropin new investment, and other innovations that are shaping the future of Human Chorionic Gonadotropin.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Chorionic Gonadotropin market. It includes factors influencing customer ' purchasing decisions, preferences for Human Chorionic Gonadotropin product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Chorionic Gonadotropin market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Chorionic Gonadotropin market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Chorionic Gonadotropin market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Chorionic Gonadotropin industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Chorionic Gonadotropin market.

Market Segmentation:

Human Chorionic Gonadotropin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Natural Source Extraction
• Recombinant Technology

Segmentation by application

• Fertility Clinics
• Research Institutions
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bristol Myers Squibb
• Merck & Co
• Ferring
• Fresenius Kabi
• Sun Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Chorionic Gonadotropin Market Size 2019-2030
  2.1.2 Human Chorionic Gonadotropin Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Human Chorionic Gonadotropin Segment by Type
  2.2.1 Natural Source Extraction
  2.2.2 Recombinant Technology
2.3 Human Chorionic Gonadotropin Market Size by Type
  2.3.1 Human Chorionic Gonadotropin Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Human Chorionic Gonadotropin Market Size Market Share by Type (2019-2024)
2.4 Human Chorionic Gonadotropin Segment by Application
  2.4.1 Fertility Clinics
  2.4.2 Research Institutions
  2.4.3 Others
2.5 Human Chorionic Gonadotropin Market Size by Application
  2.5.1 Human Chorionic Gonadotropin Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Human Chorionic Gonadotropin Market Size Market Share by Application (2019-2024)

3 HUMAN CHORIONIC GONADOTROPIN MARKET SIZE BY PLAYER

3.1 Human Chorionic Gonadotropin Market Size Market Share by Players
  3.1.1 Global Human Chorionic Gonadotropin Revenue by Players (2019-2024)
  3.1.2 Global Human Chorionic Gonadotropin Revenue Market Share by Players (2019-2024)
3.2 Global Human Chorionic Gonadotropin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HUMAN CHORIONIC GONADOTROPIN BY REGIONS

4.1 Human Chorionic Gonadotropin Market Size by Regions (2019-2024)
4.2 Americas Human Chorionic Gonadotropin Market Size Growth (2019-2024)
4.3 APAC Human Chorionic Gonadotropin Market Size Growth (2019-2024)
4.4 Europe Human Chorionic Gonadotropin Market Size Growth (2019-2024)
4.5 Middle East & Africa Human Chorionic Gonadotropin Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Human Chorionic Gonadotropin Market Size by Country (2019-2024)
5.2 Americas Human Chorionic Gonadotropin Market Size by Type (2019-2024)
5.3 Americas Human Chorionic Gonadotropin Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human Chorionic Gonadotropin Market Size by Region (2019-2024)
6.2 APAC Human Chorionic Gonadotropin Market Size by Type (2019-2024)
6.3 APAC Human Chorionic Gonadotropin Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Human Chorionic Gonadotropin by Country (2019-2024)
7.2 Europe Human Chorionic Gonadotropin Market Size by Type (2019-2024)
7.3 Europe Human Chorionic Gonadotropin Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Chorionic Gonadotropin by Region (2019-2024)
8.2 Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2019-2024)
8.3 Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HUMAN CHORIONIC GONADOTROPIN MARKET FORECAST

10.1 Global Human Chorionic Gonadotropin Forecast by Regions (2025-2030)
  10.1.1 Global Human Chorionic Gonadotropin Forecast by Regions (2025-2030)
  10.1.2 Americas Human Chorionic Gonadotropin Forecast
  10.1.3 APAC Human Chorionic Gonadotropin Forecast
  10.1.4 Europe Human Chorionic Gonadotropin Forecast
  10.1.5 Middle East & Africa Human Chorionic Gonadotropin Forecast
10.2 Americas Human Chorionic Gonadotropin Forecast by Country (2025-2030)
  10.2.1 United States Human Chorionic Gonadotropin Market Forecast
  10.2.2 Canada Human Chorionic Gonadotropin Market Forecast
  10.2.3 Mexico Human Chorionic Gonadotropin Market Forecast
  10.2.4 Brazil Human Chorionic Gonadotropin Market Forecast
10.3 APAC Human Chorionic Gonadotropin Forecast by Region (2025-2030)
  10.3.1 China Human Chorionic Gonadotropin Market Forecast
  10.3.2 Japan Human Chorionic Gonadotropin Market Forecast
  10.3.3 Korea Human Chorionic Gonadotropin Market Forecast
  10.3.4 Southeast Asia Human Chorionic Gonadotropin Market Forecast
  10.3.5 India Human Chorionic Gonadotropin Market Forecast
  10.3.6 Australia Human Chorionic Gonadotropin Market Forecast
10.4 Europe Human Chorionic Gonadotropin Forecast by Country (2025-2030)
  10.4.1 Germany Human Chorionic Gonadotropin Market Forecast
  10.4.2 France Human Chorionic Gonadotropin Market Forecast
  10.4.3 UK Human Chorionic Gonadotropin Market Forecast
  10.4.4 Italy Human Chorionic Gonadotropin Market Forecast
  10.4.5 Russia Human Chorionic Gonadotropin Market Forecast
10.5 Middle East & Africa Human Chorionic Gonadotropin Forecast by Region (2025-2030)
  10.5.1 Egypt Human Chorionic Gonadotropin Market Forecast
  10.5.2 South Africa Human Chorionic Gonadotropin Market Forecast
  10.5.3 Israel Human Chorionic Gonadotropin Market Forecast
  10.5.4 Turkey Human Chorionic Gonadotropin Market Forecast
  10.5.5 GCC Countries Human Chorionic Gonadotropin Market Forecast
10.6 Global Human Chorionic Gonadotropin Forecast by Type (2025-2030)
10.7 Global Human Chorionic Gonadotropin Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Bristol Myers Squibb
  11.1.1 Bristol Myers Squibb Company Information
  11.1.2 Bristol Myers Squibb Human Chorionic Gonadotropin Product Offered
  11.1.3 Bristol Myers Squibb Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Bristol Myers Squibb Main Business Overview
  11.1.5 Bristol Myers Squibb Latest Developments
11.2 Merck & Co
  11.2.1 Merck & Co Company Information
  11.2.2 Merck & Co Human Chorionic Gonadotropin Product Offered
  11.2.3 Merck & Co Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Merck & Co Main Business Overview
  11.2.5 Merck & Co Latest Developments
11.3 Ferring
  11.3.1 Ferring Company Information
  11.3.2 Ferring Human Chorionic Gonadotropin Product Offered
  11.3.3 Ferring Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Ferring Main Business Overview
  11.3.5 Ferring Latest Developments
11.4 Fresenius Kabi
  11.4.1 Fresenius Kabi Company Information
  11.4.2 Fresenius Kabi Human Chorionic Gonadotropin Product Offered
  11.4.3 Fresenius Kabi Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Fresenius Kabi Main Business Overview
  11.4.5 Fresenius Kabi Latest Developments
11.5 Sun Pharmaceutical
  11.5.1 Sun Pharmaceutical Company Information
  11.5.2 Sun Pharmaceutical Human Chorionic Gonadotropin Product Offered
  11.5.3 Sun Pharmaceutical Human Chorionic Gonadotropin Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Sun Pharmaceutical Main Business Overview
  11.5.5 Sun Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES
.
Table 1. Human Chorionic Gonadotropin Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Natural Source Extraction
Table 3. Major Players of Recombinant Technology
Table 4. Human Chorionic Gonadotropin Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Human Chorionic Gonadotropin Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Human Chorionic Gonadotropin Market Size Market Share by Type (2019-2024)
Table 7. Human Chorionic Gonadotropin Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Human Chorionic Gonadotropin Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Human Chorionic Gonadotropin Market Size Market Share by Application (2019-2024)
Table 10. Global Human Chorionic Gonadotropin Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Human Chorionic Gonadotropin Revenue Market Share by Player (2019-2024)
Table 12. Human Chorionic Gonadotropin Key Players Head office and Products Offered
Table 13. Human Chorionic Gonadotropin Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Human Chorionic Gonadotropin Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Human Chorionic Gonadotropin Market Size Market Share by Regions (2019-2024)
Table 18. Global Human Chorionic Gonadotropin Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Human Chorionic Gonadotropin Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Human Chorionic Gonadotropin Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Human Chorionic Gonadotropin Market Size Market Share by Country (2019-2024)
Table 22. Americas Human Chorionic Gonadotropin Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Human Chorionic Gonadotropin Market Size Market Share by Type (2019-2024)
Table 24. Americas Human Chorionic Gonadotropin Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Human Chorionic Gonadotropin Market Size Market Share by Application (2019-2024)
Table 26. APAC Human Chorionic Gonadotropin Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Human Chorionic Gonadotropin Market Size Market Share by Region (2019-2024)
Table 28. APAC Human Chorionic Gonadotropin Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Human Chorionic Gonadotropin Market Size Market Share by Type (2019-2024)
Table 30. APAC Human Chorionic Gonadotropin Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Human Chorionic Gonadotropin Market Size Market Share by Application (2019-2024)
Table 32. Europe Human Chorionic Gonadotropin Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Human Chorionic Gonadotropin Market Size Market Share by Country (2019-2024)
Table 34. Europe Human Chorionic Gonadotropin Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Human Chorionic Gonadotropin Market Size Market Share by Type (2019-2024)
Table 36. Europe Human Chorionic Gonadotropin Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Human Chorionic Gonadotropin Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Human Chorionic Gonadotropin Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Human Chorionic Gonadotropin Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Human Chorionic Gonadotropin Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Human Chorionic Gonadotropin
Table 45. Key Market Challenges & Risks of Human Chorionic Gonadotropin
Table 46. Key Industry Trends of Human Chorionic Gonadotropin
Table 47. Global Human Chorionic Gonadotropin Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Human Chorionic Gonadotropin Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Human Chorionic Gonadotropin Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Human Chorionic Gonadotropin Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Bristol Myers Squibb Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 52. Bristol Myers Squibb Human Chorionic Gonadotropin Product Offered
Table 53. Bristol Myers Squibb Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Bristol Myers Squibb Main Business
Table 55. Bristol Myers Squibb Latest Developments
Table 56. Merck & Co Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 57. Merck & Co Human Chorionic Gonadotropin Product Offered
Table 58. Merck & Co Main Business
Table 59. Merck & Co Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Merck & Co Latest Developments
Table 61. Ferring Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 62. Ferring Human Chorionic Gonadotropin Product Offered
Table 63. Ferring Main Business
Table 64. Ferring Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Ferring Latest Developments
Table 66. Fresenius Kabi Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 67. Fresenius Kabi Human Chorionic Gonadotropin Product Offered
Table 68. Fresenius Kabi Main Business
Table 69. Fresenius Kabi Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Fresenius Kabi Latest Developments
Table 71. Sun Pharmaceutical Details, Company Type, Human Chorionic Gonadotropin Area Served and Its Competitors
Table 72. Sun Pharmaceutical Human Chorionic Gonadotropin Product Offered
Table 73. Sun Pharmaceutical Main Business
Table 74. Sun Pharmaceutical Human Chorionic Gonadotropin Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Sun Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES
.
Figure 1. Human Chorionic Gonadotropin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Chorionic Gonadotropin Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Human Chorionic Gonadotropin Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Human Chorionic Gonadotropin Sales Market Share by Country/Region (2023)
Figure 8. Human Chorionic Gonadotropin Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Human Chorionic Gonadotropin Market Size Market Share by Type in 2023
Figure 10. Human Chorionic Gonadotropin in Fertility Clinics
Figure 11. Global Human Chorionic Gonadotropin Market: Fertility Clinics (2019-2024) & ($ Millions)
Figure 12. Human Chorionic Gonadotropin in Research Institutions
Figure 13. Global Human Chorionic Gonadotropin Market: Research Institutions (2019-2024) & ($ Millions)
Figure 14. Human Chorionic Gonadotropin in Others
Figure 15. Global Human Chorionic Gonadotropin Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Human Chorionic Gonadotropin Market Size Market Share by Application in 2023
Figure 17. Global Human Chorionic Gonadotropin Revenue Market Share by Player in 2023
Figure 18. Global Human Chorionic Gonadotropin Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Human Chorionic Gonadotropin Market Size 2019-2024 ($ Millions)
Figure 20. APAC Human Chorionic Gonadotropin Market Size 2019-2024 ($ Millions)
Figure 21. Europe Human Chorionic Gonadotropin Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Human Chorionic Gonadotropin Market Size 2019-2024 ($ Millions)
Figure 23. Americas Human Chorionic Gonadotropin Value Market Share by Country in 2023
Figure 24. United States Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Human Chorionic Gonadotropin Market Size Market Share by Region in 2023
Figure 29. APAC Human Chorionic Gonadotropin Market Size Market Share by Type in 2023
Figure 30. APAC Human Chorionic Gonadotropin Market Size Market Share by Application in 2023
Figure 31. China Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Human Chorionic Gonadotropin Market Size Market Share by Country in 2023
Figure 38. Europe Human Chorionic Gonadotropin Market Size Market Share by Type (2019-2024)
Figure 39. Europe Human Chorionic Gonadotropin Market Size Market Share by Application (2019-2024)
Figure 40. Germany Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Human Chorionic Gonadotropin Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Human Chorionic Gonadotropin Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 54. APAC Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 55. Europe Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 57. United States Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 58. Canada Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 61. China Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 62. Japan Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 63. Korea Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 65. India Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 66. Australia Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 67. Germany Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 68. France Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 69. UK Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 70. Italy Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 71. Russia Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 72. Spain Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 75. Israel Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Human Chorionic Gonadotropin Market Size 2025-2030 ($ Millions)
Figure 78. Global Human Chorionic Gonadotropin Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Human Chorionic Gonadotropin Market Size Market Share Forecast by Application (2025-2030)